[144] Stoke Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Insider proposed sale and recent activity disclosed. This Form 144 notifies the proposed sale of 22,117 common shares of the issuer via Morgan Stanley Smith Barney, with an aggregate market value of $437,253.09 and an approximate sale date of 08/29/2025 on NASDAQ. The filing shows acquisition details: 10,000 shares acquired on 08/29/2025 by exercise of stock options (paid in cash) and 12,117 shares from restricted stock units acquired on 12/01/2024. The filer previously sold 1,683 shares on 08/18/2025 for $30,694.55 and 13,712 shares on 08/13/2025 for $205,680.00. The notice includes the required attestation regarding material nonpublic information.

Positive

• Full disclosure of proposed sale including broker, share count, market value, and planned NASDAQ execution
• Acquisition details provided (option exercise and RSUs) and payment method for the exercised options (cash)
• Recent past sales disclosed for transparency: 13,712 shares on 08/13/2025 and 1,683 shares on 08/18/2025

Negative

• Insider selling activity: proposed sale of 22,117 shares ($437,253.09) and recent August disposals totaling 15,395 shares may be viewed negatively by some investors
• No 10b5-1 plan adoption date provided in the remarks, so reliance on a trading plan is not documented in this filing

Insights

Securities Analyst

TL;DR Insider proposes to sell 22,117 shares (~$437k) after recent disposals; this is a notable insider liquidity event.

The filing documents a planned sale of 22,117 common shares through Morgan Stanley with an aggregate market value of $437,253.09 and an intended execution on NASDAQ on 08/29/2025. Acquisition records show 10,000 shares from option exercise on 08/29/2025 (cash payment) and 12,117 RSU shares from 12/01/2024. Recent sales in August total 15,395 shares generating $236,374.55 in gross proceeds. For investors, the scale of insider selling is measurable relative to the outstanding shares disclosed (54,797,418), representing a small fraction (<0.05%) but indicates insider liquidity activity to note.

Compliance/Risk Analyst

TL;DR Filing includes standard attestation and broker details; shows prior sales likely executed under trading instructions.

The Form 144 contains broker identification (Morgan Stanley Smith Barney LLC) and the filer’s representation about lack of material nonpublic information. It records recent disposals on 08/13/2025 and 08/18/2025 and the planned sale on 08/29/2025. The document lists acquisition methods (option exercise and RSUs) and payment method for the option exercise (cash), meeting Rule 144 disclosure elements. No explicit 10b5-1 adoption date is provided in the remarks section.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22117	437253.09	54797418	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Exercise of Stock Options	Issuer			10000	08/29/2025	Cash
Common	12/01/2024	Restricted Stock Units	Issuer			12117	12/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JONATHAN D ALLAN 45 Wiggins Ave Bedford MA 01730	Common	08/18/2025	1683	30694.55
10b5-1 Sales for JONATHAN D ALLAN 45 Wiggins Ave Bedford MA 01730	Common	08/13/2025	13712	205680.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider is proposing to sell shares in this Form 144 for STOK?

The filing identifies the seller as Jonathan D Allan and shows the proposed sale broker as Morgan Stanley Smith Barney LLC.

How many shares and what value are proposed to be sold on 08/29/2025?

The notice reports 22,117 common shares with an aggregate market value of $437,253.09, with an approximate sale date of 08/29/2025 on NASDAQ.

What were the recent insider sales in the past three months listed in the filing?

The filing shows sales of 13,712 shares on 08/13/2025 for $205,680.00 and 1,683 shares on 08/18/2025 for $30,694.55.

How were the shares to be sold acquired?

Acquisition details: 10,000 shares via exercise of stock options on 08/29/2025 (paid in cash) and 12,117 shares as restricted stock units on 12/01/2024.

Does the filing state whether the seller knows any material nonpublic information?

Yes. By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.